Evidence map›Paper›PMID 38580565›Full record

ArticleActa biomaterialia2024

Corrigendum to "Tissue-adhesive hydrogel for multimodal drug release to immune cells in skin" [Acta Biomaterialia Volume 150, Pages 211-220].

Nicole B Day, Rianne Dalhuisen, Nichole E Loomis, Sarah G Adzema, Jai Prakash, C Wyatt Shields

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Acta biomaterialia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Nicole B DayDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder CO 80303, United States.
Rianne DalhuisenDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder CO 80303, United States; Department of Advanced Organ Bioengineering and Therapeutics, Section: Engineered Therapeutics, University of Twente, Enschede, the Netherlands.
Nichole E LoomisDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder CO 80303, United States.
Sarah G AdzemaDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder CO 80303, United States.
Jai PrakashDepartment of Advanced Organ Bioengineering and Therapeutics, Section: Engineered Therapeutics, University of Twente, Enschede, the Netherlands.
C Wyatt ShieldsDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder CO 80303, United States; Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, United States. Electronic address: Charles.Shields@colorado.edu.

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
NIGMS NIH HHS T32 GM065103
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38580565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.